Search Results - "Aksam, Rukia"
-
1
Second-Line Switch to Dolutegravir for Treatment of HIV Infection
Published in The New England journal of medicine (22-06-2023)“…In an open-label, multicenter trial in Kenya, HIV-infected patients following a ritonavir-boosted protease inhibitor regimen were assigned to switch to…”
Get full text
Journal Article -
2
Switching treatment-experienced, integrase inhibitor-naïve, virally suppressed HIV-1 infected adults from ritonavir-boosted protease inhibitors to dolutegravir: design, methods, and baseline results of a randomized, open-label, non-inferiority trial [version 1; peer review: awaiting peer review]
Published in F1000 research (2022)“…Background: Most HIV-positive adults in Kenya with prior non-nucleoside reverse transcriptase inhibitor (NNRTI) failure are currently on ritonavir-boosted…”
Get full text
Journal Article